Universal Redirection of Chimeric Antigen Receptor T Cells Against Solid Tumors via Tumor Cell Membrane-Inserting CAR Ligands

Researchers

Angela Zhang / Laura Chen / Alexander Hostetler / Darrell J Irvine

Departments: Biological Engineering, David H Koch Institute for Integrative Cancer Res
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living

  • car cells targeting an inserted ligand
    United States of America | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.